Genfit S.A. (OTCMKTS:GNFTF – Get Free Report) was the target of a significant growth in short interest in the month of September. As of September 30th, there was short interest totaling 37,557 shares, a growth of 7,192.6% from the September 15th total of 515 shares. Based on an average daily trading volume, of 0 shares, the short-interest ratio is presently ∞ days.
Genfit Price Performance
Shares of Genfit stock remained flat at $15.75 during trading on Friday. The company’s 50-day simple moving average is $15.84 and its 200 day simple moving average is $12.55. Genfit has a 1 year low of $4.14 and a 1 year high of $16.50.
Genfit Company Profile
Genfit SA is a France-based biopharmaceutical company focused on developing medicines and diagnostic solutions for metabolic, liver and rare diseases. The company’s research programs target conditions with significant unmet medical needs, including metabolic dysfunction-associated steatohepatitis (MASH), primary biliary cholangitis and other progressive liver disorders.
Genfit’s pipeline has included investigational therapies designed to address liver inflammation, fibrosis and related metabolic complications.
See Also
- Five stocks we like better than Genfit
- Alphabet Introduces Gemini Agent—Can It Trigger a Breakout?
- Palantir’s Rally Puts Wall Street in Catch-Up Mode Ahead of November Earnings
- Tilray Finds a Path to Growth Without Waiting on U.S. Cannabis Reform
- Arista Networks Plugs Into All-Time Highs
Receive News & Ratings for Genfit Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genfit and related companies with MarketBeat.com's FREE daily email newsletter.
